MM
Insider
Michael F MacLean
Chief Financial OfficerMichael F MacLean (Chief Financial Officer) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in RNA. The largest single filing was $329K of RNA (4,542 sh across 2 lots, as filed), executed Jan 21. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$472K
shares × price, as filed
Last traded
Jan 21
Filed Jan 23
Volume by month
Buys $0
Sells $2.4M
Shares × price, as filed · by filing month · past 24 months
Most traded names
RNA
RNA
0 buys · 6 sells
6 filings
Recent filings
RNASALE
Avidity Biosciences, Inc.
View filing →
$329K4,542 sh across 2 lots
Exec Jan 21
Filed Jan 23 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $143K
1,974 sh × $72.23
Exec Jan 7
Filed Jan 9 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $1.3M
30,914 sh × $42.73
Exec Aug 6 2025
Filed Aug 15 2025 · 5:30 PM ET † RNASALE Avidity Biosciences, Inc. View filing → $246K
7,935 sh × $31.06
Exec Mar 20 2025
Filed Mar 21 2025 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $364K
11,151 sh × $32.66
Exec Dec 18 2024
Filed Dec 19 2024 · 5:30 PM ET RNASALE Avidity Biosciences, Inc. View filing → $4.8M
106,319 sh across 3 lots
Exec Nov 6 2024
Filed Nov 8 2024 · 5:30 PM ET